Noninferiority study of lipegfilgrastim vs. Pegfilgrastim: A multicenter phase III study of breast cancer patients receiving myelosuppressive chemotherapy — Results from Russia

Category Primary study
JournalRussian Journal of Biopharmaceuticals
Year 2016
This article has no abstract
Epistemonikos ID: 8eeb05a8e6fb8bc71515a54a47b1671d1405d580
First added on: Feb 08, 2025